1 / 10

Solitaire FR Revascularization Device™

Solitaire FR Revascularization Device™. Jeffrey McCarthy BME181 University of Rhode Island. Objectives . Review the symptoms of a stroke Discuss why strokes occur Describe the use of the Solitaire device to treat a stroke. Symptoms of Stroke. What Causes a Stroke?.

sheng
Télécharger la présentation

Solitaire FR Revascularization Device™

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Solitaire FR Revascularization Device™ Jeffrey McCarthy BME181 University of Rhode Island

  2. Objectives • Review the symptoms of a stroke • Discuss why strokes occur • Describe the use of the Solitaire device to treat a stroke

  3. Symptoms of Stroke

  4. What Causes a Stroke?

  5. Treatment Options for Stroke • Time from symptom onset • < 3 or < 4.5 hours • “clot buster” medication • tPA (Alteplase) • Greater than 4.5 hours OR ineligible for tPA • Mechanical thrombectomy • Up to 8 hours from symptom onset

  6. Finding the Clot Normal Angiography Angiography showing a Stroke

  7. Solitaire in Action

  8. Solitaire Device • http://www.youtube.com/watch?v=0DQPD5TTS5Y

  9. Effectiveness of Solitaire Device

  10. References: 1.) “Solitaire FR Revascularization Device” Covidien. 27 Feb 2013 <http://www.ev3.net/neuro/intl/flow-restoration/solitaire-fr- revascularization-device.htm> 2.) Saver, JL Jahon R, Levy EI. Solitaire flow restoration device versus the Merci Retreiver in patients with acute ischaemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial. The Lancet, 380(9849), 1241-1249 2012. 3.) “About Stroke” American Stroke Association. 27 Feb. 2013 <http://www.strokeassociation.org/STROKEORG/AboutStroke/About- Stroke_UCM_308529_SubHomePage.jsp>

More Related